Clinical updates from Asia-Pacific, including data readouts and publications: Innocare, Jyong, Kazia.

Biopharma happenings in Asia-Pacific including deals and partnerships, and other news in brief: Alps Group, Amgen, Bayer, BNC Korea, Boehringer Ingelheim, Chia Tai Feng Hai, Formation, Hanchorbio, Hanmi, Hetero Group, Insilico Medicine, Kyowa Kirin, Laboratorios Sanfer, Leios Therapeutics, Lisata, Mesoblast, MS Pharma, Poxel, Qilu, Regeneron, Samsung Bioepis, Simcere, Wuxi.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Chiesi, Eli Lilly, Johnson & Johnson, Protalix, Sanofi, Ultragenyx, Unicycive.

Biopharma happenings, including deals and partnerships, and other news in brief: Alps, Amgen, Astrazeneca, Bayer, IO Biotech, Kyowa, Moderna, Poxel, Recordati, Regeneron, Samsung Bioepsis.

Clinical updates, including data readouts and publications: Jyong, Quince, Tonix.

Biopharmas raising money in public or private financings, including: Agomab, Altimmune, ALX, Biomarin, Coya, Lexicon, Promis, Spyglass, Vaxcyte.

New hires and promotions in the biopharma industry, including: Immunocore, Merz, Pharmnovo.

The top 10 biopharma stock gainers and losers for the week.